BDBM347264 US10202411, Compound 326
SMILES: Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](CF)[C@H]1O
InChI Key: InChIKey=NKTQCJIRNHTYAB-HUKYDQBMSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NS3 serine protease (NS3) (Hepatitis C Virus (Virus)) | BDBM347264![]() (US10202411, Compound 326) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet ![]() | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
IDENIX PHARMACEUTICALS LLC US Patent | Assay Description Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac... | US Patent US10202411 (2019) BindingDB Entry DOI: 10.7270/Q2RX9F67 | |||||||||||
More data for this Ligand-Target Pair |